SOPHiA GENETICS medical chief sells 5,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SOPHiA GENETICS SA (SOPH) Chief Medical Officer Philippe Menu sold 5,000 ordinary shares on November 12, 2026, at a weighted average price of $7.6799 per share. The sale was made under a Rule 10b5-1(c) trading plan. Menu directly held 190,993 shares afterward.
Insider Trade Summary 10b5-1
Net Seller: 5,000 shares
Net Sell
1 txn
Insider
Menu Philippe
Role
Chief Medical Officer
Sold
5,000 shs ($38K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2 | 5,000 | $7.6799 | $38K |
Holdings After Transaction:
Ordinary Shares — 190,993 shares (Direct)
Footnotes (2)
- F1. Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.21 to $7.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 5,000 ordinary shares
Weighted average price: $7.6799 per share
Direct shares held after sale: 190,993 shares
+1 more
4 metrics
Shares sold
5,000 ordinary shares
Philippe Menu’s sale on November 12, 2026
Weighted average price
$7.6799 per share
Philippe Menu’s sale on November 12, 2026
Direct shares held after sale
190,993 shares
Philippe Menu’s reported position following the sale
Transaction price range
$7.21 to $7.92 per share
Prices across multiple transactions, inclusive
Key Terms
Rule 10b5-1(c), weighted average price
2 terms
Rule 10b5-1(c) regulatory
"duly adopted trading plan under Rule 10b5-1(c)"
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.